{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:50:43Z","timestamp":1790095843389,"version":"4.0.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute (US)","award":["1R21 CA179668-01A1"],"award-info":[{"award-number":["1R21 CA179668-01A1"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170197","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T18:44:09Z","timestamp":1486061049000},"page":"e0170197","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer"],"prefix":"10.1371","volume":"12","author":[{"given":"Nadine","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoly","family":"Szekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Iclozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivannie Ortiz","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbemisola","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyekachi","family":"Nwogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-4586","authenticated-orcid":true,"given":"Tomar","family":"Ghansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1756283X13478680","article-title":"Pancreatic cancer: why is it so hard to treat?","volume":"6","author":"PE Oberstein","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14712590802715756","article-title":"Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer","volume":"9","author":"MA Morse","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"e25736","DOI":"10.4161\/onci.25736","article-title":"Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer","volume":"2","author":"AV Bazhin","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Multiple roles for CD4+ T cells in anti-tumor immune responses","volume":"222","author":"R Kennedy","year":"2008","journal-title":"Immunol Rev"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/2326-6066.CIR-13-0216","article-title":"CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful","volume":"2","author":"HJ Kim","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"ref6","unstructured":"Xianjun Y, Shunrong J, Jin X, Wantong Y, Bin Q, Wenyan X, Bo Z, Yongfeng X. CD8+ T Cells Are Compromised In Human Pancreatic Cancer. Translational Medicine. p. 2161\u20131025.1000105."},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"JD Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-387827-4.00004-8","article-title":"Biological functions of regulatory T cells","volume":"112","author":"EM Shevach","year":"2011","journal-title":"Adv Immunol"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","article-title":"Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions","volume":"12","author":"N Hiraoka","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00262-013-1407-9","article-title":"Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma","volume":"62","author":"T Ghansah","year":"2013","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPA.0b013e3182373a66","article-title":"Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer","volume":"41","author":"T Yamamoto","year":"2012","journal-title":"Pancreas"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1440-1711.2003.01159.x","article-title":"Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies","volume":"81","author":"A Rebollo","year":"2003","journal-title":"Immunol Cell Biol"},{"issue":"9\u201310","key":"ref13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.molimm.2011.03.006","article-title":"The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity","volume":"48","author":"LB John","year":"2011","journal-title":"Mol Immunol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/MCB.25.5.1645-1654.2005","article-title":"Ikaros induces quiescence and T-cell differentiation in a leukemia cell line","volume":"25","author":"KL Kathrein","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.4049\/jimmunol.0802869","article-title":"Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice","volume":"182","author":"JA Urban","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90170-1","article-title":"A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma","volume":"83","author":"S Winandy","year":"1995","journal-title":"Cell"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e68080","DOI":"10.1371\/journal.pone.0068080","article-title":"A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders","volume":"8","author":"D Capece","year":"2013","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.immunol.15.1.155","article-title":"The role of the Ikaros gene in lymphocyte development and homeostasis","volume":"15","author":"K Georgopoulos","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/MCB.24.7.2797-2807.2004","article-title":"Phosphorylation controls Ikaros&apos;s ability to negatively regulate the G(1)-S transition","volume":"24","author":"P G\u00f3mez-del Arco","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"20","key":"ref20","doi-asserted-by":"crossref","first-page":"13869","DOI":"10.1074\/jbc.M900209200","article-title":"Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1","volume":"284","author":"M Popescu","year":"2009","journal-title":"The Journal of biological chemistry"},{"issue":"1\u20132","key":"ref21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11010-011-0964-5","article-title":"Ikaros, CK2 kinase, and the road to leukemia","volume":"356","author":"S Dovat","year":"2011","journal-title":"Molecular and cellular biochemistry"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1074\/jbc.M707906200","article-title":"Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation","volume":"283","author":"Z Gurel","year":"2008","journal-title":"J Biol Chem"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/pbc.25221","article-title":"Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia","volume":"61","author":"H Wang","year":"2014","journal-title":"Pediatric blood & cancer"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00001813-200511000-00001","article-title":"Targeting CK2 for cancer therapy","volume":"16","author":"KA Ahmad","year":"2005","journal-title":"Anticancer Drugs"},{"issue":"11\u201312","key":"ref25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00018-009-9148-9","article-title":"Protein kinase CK2 in health and disease: Protein kinase CK2: an ugly duckling in the kinome pond","volume":"66","author":"LA Pinna","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"Pt 1","key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021469","article-title":"Protein kinase CK2: structure, regulation and role in cellular decisions of life and death","volume":"369","author":"DW Litchfield","year":"2003","journal-title":"Biochem J"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbapap.2007.08.017","article-title":"Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2","volume":"1784","author":"JS Duncan","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"ref28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11010-008-9811-8","article-title":"Gene targeting of CK2 catalytic subunits","volume":"316","author":"DC Seldin","year":"2008","journal-title":"Mol Cell Biochem"},{"issue":"23","key":"ref29","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/sj.onc.1201854","article-title":"p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice","volume":"16","author":"E Landesman-Bollag","year":"1998","journal-title":"Oncogene"},{"issue":"34","key":"ref30","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/sj.onc.1205640","article-title":"Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis","volume":"21","author":"P Channavajhala","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"ref31","first-page":"233","article-title":"Apigenin and cancer chemoprevention: progress, potential and promise (review)","volume":"30","author":"D Patel","year":"2007","journal-title":"Int J Oncol"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12672-012-0114-x","article-title":"Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors","volume":"3","author":"B Mafuvadze","year":"2012","journal-title":"Horm Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-5-76","article-title":"Apigenin inhibits pancreatic cancer cell proliferation through G2\/M cell cycle arrest","volume":"5","author":"MB Ujiki","year":"2006","journal-title":"Mol Cancer"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPA.0b013e318193a074","article-title":"The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells","volume":"38","author":"MJ Strouch","year":"2009","journal-title":"Pancreas"},{"issue":"3","key":"ref35","first-page":"695","article-title":"Casein kinase II inhibition induces apoptosis in pancreatic cancer cells","volume":"18","author":"R Hamacher","year":"2007","journal-title":"Oncol Rep"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"e0115546","DOI":"10.1371\/journal.pone.0115546","article-title":"Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis","volume":"10","author":"N Nelson","year":"2015","journal-title":"PloS one"},{"issue":"2","key":"ref37","first-page":"717","article-title":"Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL\/6 mice","volume":"44","author":"TH Corbett","year":"1984","journal-title":"Cancer research"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.4049\/jimmunol.173.12.7324","article-title":"Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses","volume":"173","author":"T Ghansah","year":"2004","journal-title":"Journal of immunology"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4331\/wjbc.v2.i6.126","article-title":"Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1","volume":"2","author":"C Song","year":"2011","journal-title":"World journal of biological chemistry"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/bcr1797","article-title":"Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts","volume":"9","author":"D Chen","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5","article-title":"Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential","volume":"87","author":"S Caltagirone","year":"2000","journal-title":"Int J Cancer"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"e27729","DOI":"10.1371\/journal.pone.0027729","article-title":"Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function","volume":"6","author":"S Pilon-Thomas","year":"2011","journal-title":"PloS one"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.4049\/jimmunol.170.6.3091","article-title":"Ikaros isoform x is selectively expressed in myeloid differentiation","volume":"170","author":"KJ Payne","year":"2003","journal-title":"J Immunol"},{"issue":"14","key":"ref44","first-page":"4095","article-title":"A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells","volume":"63","author":"Z Qin","year":"2003","journal-title":"Cancer Res"},{"issue":"15","key":"ref45","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2015-06-651505","article-title":"Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia","volume":"126","author":"C Song","year":"2015","journal-title":"Blood"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/onc.2009.434","article-title":"Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer","volume":"29","author":"GL Powers","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cbf.1459","article-title":"Effects of proteasome inhibitor, MG132, on proteasome activity and oxidative status of rat liver","volume":"26","author":"A Alexandrova","year":"2008","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(04)00120-5","article-title":"The development of proteasome inhibitors as anticancer drugs","volume":"5","author":"J Adams","year":"2004","journal-title":"Cancer Cell"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2009.09.034","article-title":"EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin","volume":"36","author":"H Ji","year":"2009","journal-title":"Mol Cell"},{"issue":"30","key":"ref50","doi-asserted-by":"crossref","first-page":"20380","DOI":"10.1016\/S0021-9258(18)54934-6","article-title":"Phosphorylation of the beta subunit of casein kinase II in human A431 cells. Identification of the autophosphorylation site and a site phosphorylated by p34cdc2","volume":"266","author":"DW Litchfield","year":"1991","journal-title":"J Biol Chem"},{"issue":"20","key":"ref51","doi-asserted-by":"crossref","first-page":"13943","DOI":"10.1016\/S0021-9258(19)49661-0","article-title":"Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis","volume":"267","author":"DW Litchfield","year":"1992","journal-title":"J Biol Chem"},{"issue":"43","key":"ref52","doi-asserted-by":"crossref","first-page":"25872","DOI":"10.1074\/jbc.270.43.25872","article-title":"Phosphorylation of casein kinase II by p34cdc2. Identification of phosphorylation sites using phosphorylation site mutants in vitro","volume":"270","author":"DG Bosc","year":"1995","journal-title":"J Biol Chem"},{"issue":"8","key":"ref53","first-page":"2112","article-title":"Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia","volume":"5","author":"L Sun","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12307-012-0127-6","article-title":"Effector CD4 and CD8 T cells and their role in the tumor microenvironment","volume":"6","author":"S Hadrup","year":"2013","journal-title":"Cancer Microenviron"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CDLI.8.3.628-631.2001","article-title":"Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65","volume":"8","author":"SA Ghanekar","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cellbi.2003.12.006","article-title":"Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction","volume":"28","author":"MD Cao","year":"2004","journal-title":"Cell Biol Int"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1124\/mol.106.024547","article-title":"Apigenin inhibits immunostimulatory function of dendritic cells: Implication of immunotherapeutic adjuvant","volume":"70","author":"MS Yoon","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"64","key":"ref58","first-page":"e3875","article-title":"Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS)","author":"N Nelson","year":"2012","journal-title":"J Vis Exp"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T09:14:52Z","timestamp":1658567692000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170197"}},"subtitle":[],"editor":[{"given":"Chunhua","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170197","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}